Personalisierte Therapie von ROS1+ und NTRK+ NSCLC
Crossref DOI link: https://doi.org/10.1007/s15004-019-7247-9
Published Online: 2020-02-10
Published Print: 2020-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hafner, Ulrike
Text and Data Mining valid from 2020-02-01
Version of Record valid from 2020-02-01
Article History
First Online: 10 February 2020
Free to read: This content has been made available to all.